Nanotechnology Based Approaches for Tuberculosis Treatment - 1st Edition - ISBN: 9780128198117

Nanotechnology Based Approaches for Tuberculosis Treatment

1st Edition

Editors: Prashant Kesharwani
Paperback ISBN: 9780128198117
Imprint: Academic Press
Published Date: 2nd June 2020
Page Count: 370
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Nanotechnology Based Approaches for Tuberculosis Treatment discusses multiple nanotechnology-based approaches which may help overcome persisting limitations of conventional and traditional treatment of Tuberculosis. A quarter of the world’s population is infected with Tuberculosis, and despite potentially curative pharmacotherapies being available for over 50 years, Tuberculosis deaths persist, and multidrug-resistant strains of TB are emerging due to prolonged treatment, high pill burden, and low patient compliance. This book summarizes the types of nano drugs, their synthesis, formulation, characterization, and applications, along with the most important administration routes. It also explores recent advances and achievements regarding therapeutic efficacy and provides possible future applications in this field. It directly addresses translational aspects and clinical perspectives of tuberculosis nanomedicine from a comprehensive and multidisciplinary perspective. Nanotechnology Based Approaches for Tuberculosis Treatment will be a useful resource for investigators, pharmaceutical researchers, innovators, and scientists working on technology advancement in the areas of designing targeted therapies, nano scale imaging systems and diagnostic modalities in tuberculosis. This book will also cater to the basic needs of students and new researchers in the fields of tuberculosis and nanomedicine

Key Features

  • Addresses the gap between nanomedicine late discovery and early development of tuberculosis therapeutics
  • Explores tuberculosis nanomedicine standardization and characterization with newly developed treatment, diagnostic and treatment monitoring modalities
  • Covers the field thoroughly from pathogenesis of tuberculosis and multi-drug resistant mycobacterium tuberculosis to treatment approaches using nanotechnology and different nanocarriers

Readership

Researchers, early-career investigators, and graduate students working in the pharmaceutical industries, nanomedicine, or infectious diseases

Table of Contents

  1. Tuberculosis: Introduction, drug regimens and multidrug-resistance
    2. Pathogenesis and Immunology of tuberculosis
    3. Role of essential trace elements in tuberculosis infection
    4. Multi-drug resistant mycobacterium tuberculosis & oxidative stress complexity
    5. Inhalable polymeric dry powders for anti-tuberculosis drug delivery
    6. Nanotechnology based approaches in tuberculosis treatment
    7. Liposome and niosmoes based drug delivery systems for tuberculosis treatment
    8. Nanoparticle based drug delivery systems for tuberculosis treatment
    9. Microemulsions and nanoemulsion based drug delivery systems for tuberculosis treatment
    10. Dendrimer and polymeric micelle based drug delivery systems for tuberculosis treatment
    11. Nanostructured lipid carrier based drug delivery systems for tuberculosis treatment
    12. DNA markers and nano-biosensing approaches for tuberculosis diagnosis
    13. Agility of quantitative proteomics in tuberculosis research
    14. Recent advancement and future perspective for the treatment of multidrug resistant-tuberculosis

Details

No. of pages:
370
Language:
English
Copyright:
© Academic Press 2020
Published:
2nd June 2020
Imprint:
Academic Press
Paperback ISBN:
9780128198117

About the Editor

Prashant Kesharwani

Dr. Prashant Kesharwani is currently working as Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He received his doctoral degree in Pharmaceutical Sciences from the Dr H.S. Gour University (Sagar, India) with Prof N.K Jain’s group. He is a recipient of several internationally acclaimed awards viz “Ramanujan Fellowship, DST, India-2017”, “Excellence Research Award-2014”, “Young Innovator Award (Gold medal)-2012”, “International Travel Award/Grant from DST (New Delhi), and INSA (CCSTDS, Chennai)-2012”. He has received ICMR Senior Research Fellowship (in PhD) and AICTE Junior Research Fellowship (in M. Pharm.). After his doctorate, he worked as postdoctoral fellows in the Wayne State University, Detroit (Michigan, USA). Dr. Kesharwani subsequently joined the School of Pharmacy, International Medical University (Malaysia) as lecturer in Pharmaceutical Technology. Subsequently he joined Central Drug Research Institute (CDRI), Lucknow as Ramanujan Fellow. An overarching goal of his current research is the development of nano-engineered drug delivery systems for cancer through with prime focus on dendrimer and polymeric nanomicelles mediated drug delivery systems. Dr. Kesharwani is a co-author on more than 120 publications in high impact factor international journals and 4 international books with total citations of more than 3300 (h index is 27 and i-10 index is 65 as per Google Scholar).

Affiliations and Expertise

Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India

Ratings and Reviews